TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31199849

Group type: EXPERIMENTAL
Intervention: Multi-component breastfeeding support intervention (antenatal education, professional and peer support, delivered in hospital and home settings for six months)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Multi-component breastfeeding support intervention
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Multi-component breastfeeding support intervention (compliance with all three components)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 362
Study: 28107560

Group type: EXPERIMENTAL
Intervention: Volume-stable collagen matrix (VCMX)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Autogenous subepithelial connective tissue graft (SCTG)
Number of subjects: 20
Study: 25878180

Group type: EXPERIMENTAL
Intervention: Patients with mild Alzheimer's disease (AD) dementia
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Patients with mild cognitive impairment
Number of subjects: 87

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 87
Study: 23746490

Group type: EXPERIMENTAL
Intervention: VR conversation
Number of subjects: 26

Group type: COMPARATOR
Intervention: In vivo conversation
Number of subjects: 26
Study: 20538293

Group type: EXPERIMENTAL
Intervention: Active laser therapy (n = 25), using Ga-As laser device with wavelength of 904 nm, power of 5 mW, and spot size of 0.2 cm², applied three times a week for 12 weeks, total energy of 300 mjoules over seven points (1.5 joules/cm²).
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo therapy (n = 25), where the laser was disabled but appeared functional.
Number of subjects: 50
Study: 19070889

Group type: COMPARATOR
Intervention: Standard surgery (hysterectomy and BSO, peritoneal washings, and palpation of para-aortic nodes)
Number of subjects: 1408

Group type: EXPERIMENTAL
Intervention: Standard surgery plus lymphadenectomy
Number of subjects: 1408
Study: 16871726

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention with home care and access to care team via call center
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention
Number of subjects: 157
Study: 11895893

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg
Number of subjects: 456

Group type: COMPARATOR
Intervention: Tamoxifen 20 mg
Number of subjects: 456
Study: 10367757

Group type: EXPERIMENTAL
Intervention: Chiropractic therapy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Non-PMS group (control)
Number of subjects: 54
Study: 7777014

Group type: EXPERIMENTAL
Intervention: Isotretinoin therapy
Number of subjects: 177216
Study: 2184634

Group type: EXPERIMENTAL
Intervention: Total stripping of the long saphenous vein (Group A)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Partial stripping of the long saphenous vein (Group B)
Number of subjects: 163
Study: 7403330

Group type: EXPERIMENTAL
Intervention: Intravenous administration of dextrose and water with different magnesium, calcium, and potassium solutions
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sequential regulation of oral water intake to induce 1, 2, 4, and 8 liters of urine volume/day on a low sodium diet (40 mEq)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sequential regulation of oral water intake to induce 1, 2, 4, and 8 liters of urine volume/day on a high sodium diet (200 mEq)
Number of subjects: 9
Study: 31765657

Group type: EXPERIMENTAL
Intervention: 150 mg testosterone gel
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 29718751

Group type: EXPERIMENTAL
Intervention: Topical natamycin
Number of subjects: 216

Group type: COMPARATOR
Intervention: Topical voriconazole
Number of subjects: 216
Study: 29206826

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 18
Study: 26304934

Group type: EXPERIMENTAL
Intervention: Pharmacoinvasive (PI) strategy
Number of subjects: 1701

Group type: COMPARATOR
Intervention: Primary percutaneous coronary intervention (PPCI)
Number of subjects: 1701
Study: 23794696

Group type: EXPERIMENTAL
Intervention: Conventional pre‐adjusted edgewise brackets and elastomeric ligatures
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Conventional pre‐adjusted edgewise brackets and Super Slick(®) low friction elastomeric ligatures
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Damon 3MX(®) passive self‐ligating brackets
Number of subjects: 45
Study: 21945262

Group type: EXPERIMENTAL
Intervention: HerpV+QS‐21 (saponin adjuvant)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: HerpV
Number of subjects: 35

Group type: COMPARATOR
Intervention: QS‐21
Number of subjects: 35

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 35
Study: 18297973

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 80
Study: 16881771

Group type: EXPERIMENTAL
Intervention: Child friendship training (CFT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Delayed treatment control (DTC)
Number of subjects: 100
Study: 14567768

Group type: EXPERIMENTAL
Intervention: Transdermal 17beta-estradiol plus intermittent medroxyprogesterone acetate (MPA)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 118
Study: 10197829

Group type: EXPERIMENTAL
Intervention: Education-based group intervention
Number of subjects: 312

Group type: COMPARATOR
Intervention: Peer discussion group intervention
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Education plus peer discussion (combination)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 312
Study: 7767193

Group type: EXPERIMENTAL
Intervention: Self medication programme
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 88
Study: 2264700

Group type: EXPERIMENTAL
Intervention: Biostim (immunomodulating agent)
Number of subjects: 3008
Study: 387230

Group type: EXPERIMENTAL
Intervention: Monotherapy with L-PAM
Number of subjects: 0

Group type: COMPARATOR
Intervention: Polychemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy with local irradiation
Number of subjects: 0
Study: 30630560

Group type: EXPERIMENTAL
Intervention: Remifentanil combined anesthesia
Number of subjects: 154

Group type: COMPARATOR
Intervention: Fentanyl combined anesthesia
Number of subjects: 154
Study: 27639755

Group type: EXPERIMENTAL
Intervention: Single-dose simulation education with structured debriefing and verbal feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 27053091

Group type: EXPERIMENTAL
Intervention: Sublobar resection
Number of subjects: 339

Group type: COMPARATOR
Intervention: Lobectomy
Number of subjects: 339
Study: 25185456

Group type: EXPERIMENTAL
Intervention: Acupuncture plus medication (nifedipine 5 mg once daily and beraprost 20 mg three times daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Medication only (nifedipine 5 mg once daily and beraprost 20 mg three times daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Acupuncture plus medication
Number of subjects: 14
Study: 22045030

Group type: EXPERIMENTAL
Intervention: Sulforaphane-rich beverage (SFR)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Glucoraphanin-rich beverage (GRR)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both SFR and GRR
Number of subjects: 50

Group type: COMPARATOR
Intervention: SFR
Number of subjects: 50
Study: 19207781

Group type: EXPERIMENTAL
Intervention: Ablation guided by barium visualization of the esophageal course using a limit of 15 W
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Ablation guided by barium visualization using 25 W and 'short burns' (max. 5 sec)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Ablation without visualization of the esophagus using 25 Watt (W) power limit on the posterior wall
Number of subjects: 175
Study: 18008255

Group type: EXPERIMENTAL
Intervention: Prevalent HSV‐2 infection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bacterial vaginosis (BV)
Number of subjects: 0
Study: 15831776

Group type: EXPERIMENTAL
Intervention: Adinazolam (10 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: N-desmethyl adinazolam (NDMAD, 10 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Alprazolam (1 mg)
Number of subjects: 9
Study: 11978337

Group type: EXPERIMENTAL
Intervention: BCG vaccination (Glaxo 1077)
Number of subjects: 663

Group type: COMPARATOR
Intervention: Placebo or no vaccine
Number of subjects: 663
Study: 9704254

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study: 8556082

Group type: EXPERIMENTAL
Intervention: Methylcellulose lubricating drops every 2 hours (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Polyethylene film moisture chamber (n = 30)
Number of subjects: 60
Study: 28867396

Group type: EXPERIMENTAL
Intervention: Behavioral counseling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Technology-based self-monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined behavioral counseling and technology-based self-monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline advice
Number of subjects: 0
Study: 28482385

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii (250 mg/d) orally
Number of subjects: 408

Group type: COMPARATOR
Intervention: Control group (antibiotic therapy and conventional treatment)
Number of subjects: 408
Study: 25594434

Group type: EXPERIMENTAL
Intervention: Closed-loop control (CLC) for 5 consecutive nights (23:00-07:00h)
Number of subjects: 10
Study: 24045253

Group type: EXPERIMENTAL
Intervention: 128-slice dual-source CT (DSCT) scanner
Number of subjects: 100

Group type: COMPARATOR
Intervention: 64-slice MDCT scanner
Number of subjects: 100
Study: 21949219

Group type: EXPERIMENTAL
Intervention: FII algorithm (same dose as meal A) applied to meal B (41 g carbohydrate)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Carbohydrate counting applied to meal A (75 g carbohydrate)
Number of subjects: 28
Study: 19840302

Group type: EXPERIMENTAL
Intervention: New baby wipe formulation
Number of subjects: 63

Group type: COMPARATOR
Intervention: Water and washcloth
Number of subjects: 63
Study: 18035730

Group type: EXPERIMENTAL
Intervention: Meropenem (1.5-3 g daily)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard antibacterial therapy (betalactams, fluoroquinolones, aminoglycosides, metronidazole)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard antibacterial therapy
Number of subjects: 135
Study: 15577653

Group type: EXPERIMENTAL
Intervention: N-9 gel
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 180
Study: 11745232

Group type: EXPERIMENTAL
Intervention: Chest X-ray screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 0
Study: 9046946

Group type: EXPERIMENTAL
Intervention: Surgical management of carotid atherosclerosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 0
Study: 8233251

Group type: EXPERIMENTAL
Intervention: 15-minute dosing protocol (incremental dose 1 mU/minute until 5 mU/minute, then 1 or 2 mU/minute)
Number of subjects: 865

Group type: COMPARATOR
Intervention: 40-minute dosing protocol (incremental dose 1.5 mU/minute until 7 mU/minute, then 1.5 or 3.0 mU/minute)
Number of subjects: 865

Group type: EXPERIMENTAL
Intervention: 15-minute dosing protocol
Number of subjects: 865

Group type: COMPARATOR
Intervention: 40-minute dosing protocol
Number of subjects: 865
Study: 3630857

Group type: EXPERIMENTAL
Intervention: Zinc picolinate (50 mg elemental zinc per day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Zinc gluconate (50 mg elemental zinc per day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Zinc citrate (50 mg elemental zinc per day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30770035

Group type: EXPERIMENTAL
Intervention: Victims are female in conflicts
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Interpersonal physical violence
Number of subjects: 370
Study: 29611712

Group type: EXPERIMENTAL
Intervention: Yoga-based intervention
Number of subjects: 375
Study: 29802491

Group type: EXPERIMENTAL
Intervention: Adolescent sucrose intake (Q1 vs Q4)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Premenarcheal total carbohydrates intake (Q1 vs Q4)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Adolescent fiber intake
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Adolescent fructose intake
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Early adulthood total carbohydrates, glycemic index/load, fiber, and simple sugars intake
Number of subjects: 182
Study: 27806024

Group type: EXPERIMENTAL
Intervention: Dendritic cells (DCs) and cytokine-induced killer (CIK) cells infusion (20 mL DCs and CIK cells >1.0×10¹° cells) and 500,000 U interleukin (IL)-2 for 3 days
Number of subjects: 31

Group type: COMPARATOR
Intervention: Cisplatin (30 mg/m²) and 500,000 U IL-2 for 3 days
Number of subjects: 31
Study: 23996918

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 88
Study: 21153642

Group type: EXPERIMENTAL
Intervention: Phonophoresis with betamethasone in conjunction with wrist splint use (group I, n: 18)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Iontophoresis with betamethasone in conjunction with wrist splint use (group II, n: 16)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Wrist splint use alone (control, group III, n: 18)
Number of subjects: 52
Study: 21265282

Group type: EXPERIMENTAL
Intervention: Home spirometry with data transfer via Bluetooth-equipped cell phones
Number of subjects: 56

Group type: COMPARATOR
Intervention: Home spirometry alone
Number of subjects: 56
Study: 18855271

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of trandolapril and verapamil (FDTV) 2/180 mg once a day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Trandolapril (T) 2 mg once a day
Number of subjects: 40
Study: 15889944

Group type: EXPERIMENTAL
Intervention: Phenytoin 100 mg, increased to 3 times daily (maximum 400 mg/day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Fluoxetine 7 mg, increased to 20 mg/day (3 times daily)
Number of subjects: 33
Study: 12579547

Group type: EXPERIMENTAL
Intervention: Self-administered behavioral treatment with written manuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First-line pharmacotherapies (nicotine gum, nicotine patch, bupropion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-administered pharmacotherapies under real-world conditions
Number of subjects: 0
Study: 10584635

Group type: EXPERIMENTAL
Intervention: Pulsatile tocolysis (bolus tocolysis) and oral application of magnesium
Number of subjects: 59

Group type: COMPARATOR
Intervention: Continuous tocolysis and oral application of magnesium
Number of subjects: 59

Group type: COMPARATOR
Intervention: Continuous tocolysis and parenteral application of magnesium
Number of subjects: 59
Study: 8607241

Group type: COMPARATOR
Intervention: Standard dose of 67.2 Gy
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Higher dose of 75.6 Gy
Number of subjects: 202
Study: 1931239

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 158

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 158
Study: 6179524

Group type: EXPERIMENTAL
Intervention: Interferon for 12 months
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 8
Study: 31023381

Group type: EXPERIMENTAL
Intervention: Motherfit group therapy (8 sessions of 60 min each, supervised by a registered pelvic physiotherapist)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Motherfit group therapy
Number of subjects: 240

Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 240
Study: 28138164

Group type: COMPARATOR
Intervention: Caudal block with bupivacaine 0.25% (0.50 ml/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Subcutaneous morphine (100 mcg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dorsal penile nerve block with bupivacaine 0.25% (1 mg/kg)
Number of subjects: 60
Study: 26474358

Group type: EXPERIMENTAL
Intervention: Cefepime
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 175

Group type: COMPARATOR
Intervention: No response at 48 h
Number of subjects: 175

Group type: COMPARATOR
Intervention: Response at 48 h
Number of subjects: 175

Group type: COMPARATOR
Intervention: AKI at enrolment
Number of subjects: 175

Group type: COMPARATOR
Intervention: Pneumonia
Number of subjects: 175

Group type: COMPARATOR
Intervention: Septic shock
Number of subjects: 175
Study: 25135646

Group type: EXPERIMENTAL
Intervention: Asthmatic subjects
Number of subjects: 744
Study: 22211737

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide partial pulpotomy (PP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Formocresol pulpotomy (FP)
Number of subjects: 56
Study: 19639917

Group type: EXPERIMENTAL
Intervention: Contemporary factors influencing professional development in health research
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evidence-based practice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Government concerns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual career researcher considerations
Number of subjects: 0
Study: 17581176

Group type: COMPARATOR
Intervention: Canal prepared with a D.T. Light Post #1 drill (control)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Canal prepared with a D.T. Light Post #2 drill
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Canal prepared with a D.T. Light Post #3 drill
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Canal prepared with a Gates Glidden #6 drill
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Coronal third of the root canal
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Apical third of the root canal
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Middle third of the root canal
Number of subjects: 32
Study: 15279533

Group type: EXPERIMENTAL
Intervention: PCIT
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard community-based parenting group (Control)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: PCIT plus individualized enhanced services
Number of subjects: 110
Study: 11515616

Group type: EXPERIMENTAL
Intervention: COBE Spectra Version 4.7
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: COBE Spectra Version 6
Number of subjects: 20

Group type: COMPARATOR
Intervention: Haemonetics MCS+
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: COBE Spectra Version 4.7 and COBE Spectra Version 6
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All machines
Number of subjects: 20
Study: 9760644

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (60% of maximal aerobic power)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Rest (no exercise)
Number of subjects: 22
Study: 8167386

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CyA)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 3412049

Group type: EXPERIMENTAL
Intervention: Binedaline (100 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Imipramine (50 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Binedaline with alcohol (0.8 g/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Imipramine with alcohol (0.8 g/kg)
Number of subjects: 12
Study: 31978524

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine
Number of subjects: 161

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 161
Study: 30777570

Group type: EXPERIMENTAL
Intervention: Methylprednisolone injection (1 g in two 500 mg doses)
Number of subjects: 45
Study: 27815101

Group type: EXPERIMENTAL
Intervention: Device imaging (TCEP)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Control imaging
Number of subjects: 363
Study: 25973434

Group type: EXPERIMENTAL
Intervention: Bromocriptine, 2.5 mg oral, twice a day for 14 days after delivery
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 76
Study: 23172272

Group type: EXPERIMENTAL
Intervention: Allogeneic mesenchymal stem cells (MSCs) - 100 × 10⁶ cells/infusion, 4 monthly infusions
Number of subjects: 62

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 62
Study: 20589677

Group type: EXPERIMENTAL
Intervention: Immunochemical fecal occult blood testing (I-FOBT; OC-Sensor®)
Number of subjects: 4460265
Study: 19964884

Group type: EXPERIMENTAL
Intervention: Sensory-enhanced robot-aided motor training (SERMT)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Robot-aided motor training only (RMT)
Number of subjects: 9
Study: 17711564

Group type: EXPERIMENTAL
Intervention: Dextrose normal saline (DS)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ringer's lactate (RL)
Number of subjects: 120
Study: 15078765

Group type: EXPERIMENTAL
Intervention: PercussiveTech HF (PTHF) device
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard manual chest physiotherapy (CPT)
Number of subjects: 10
Study: 12594105

Group type: EXPERIMENTAL
Intervention: ASAS improvement criteria (ASAS‐IC)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Expert panel consensus
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Provisional criteria sets
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: All criteria sets and ASAS‐IC
Number of subjects: 55
Study: 9612872

Group type: EXPERIMENTAL
Intervention: Hygienic measures (change of toothbrush, bed linen, washing of toys)
Number of subjects: 114

Group type: COMPARATOR
Intervention: No hygienic measures
Number of subjects: 114
Study: 7648682

Group type: EXPERIMENTAL
Intervention: Nifedipine (30 to 50 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nifedipine (60 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nifedipine (80 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nifedipine (any dose)
Number of subjects: 16